Peter D. Kies

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

INO

Current role

CFO

1 call Latest call 2026-03-12

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$514,604	—	$117,479	$117,927	$68,236	$15,438	$833,684
2024	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$506,806	—	$131,957	$127,982	$158,123	$15,204	$940,072
2023	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$622,881	—	$132,252	$218,593	$172,314	$15,000	$1,161,040
2022	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$518,552	—	$463,358	$466,386	$155,940	$14,232	$1,618,468
2021	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$496,168	—	$750,726	$860,581	$178,960	$11,382	$2,297,817
2020	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$445,639	—	$1,499,996	—	$198,260	$10,010	$2,153,905
2019	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$523,285	—	$215,096	$216,712	$177,833	$10,010	$1,142,936
2018	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer	$449,886	—	$354,783	$358,612	$158,321	$10,010	$1,331,612
2017	Inovio Pharmaceuticals, Inc. (INO)	Chief Financial Officer Laurent M. Humeau Chief Scientific Officer	$452,777	—	$409,484	$437,586	$137,530	$10,010	$1,447,387

Earnings-call appearances and filed executive appointments or departures, newest first.